Johnson & Johnson Executive Says Vaccine Works Where It Counts: Preventing Deaths
by Ailsa Chang
Jan 29, 2021
3 minutes
Dr. Paul Stoffels, the chief scientific officer at Johnson & Johnson, told NPR on Friday that the topline results from the company's coronavirus vaccine study fail to tell the full story about just how effective it actually is.
Johnson & Johnson said that 28 days after vaccination, its vaccine is 66% effective in preventing moderate to severe cases of COVID-19. But Stoffels says that Johnson & Johnson's vaccine is very effective where it matters most: preventing hospitalizations and deaths.
"We showed that there was an 85% efficacy against severe disease and a complete protection against hospitalization and
You’re reading a preview, subscribe to read more.
Start your free 30 days